Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing

Curr Oncol. 2024 Mar 19;31(3):1556-1561. doi: 10.3390/curroncol31030118.ABSTRACTDuctal adenocarcinoma of the prostate (DAP) is an uncommon variant of prostate cancer associated with aggressive disease and poor outcome. It presents most frequently as a mixed tumor combined with acinar adenocarcinoma. Although the histopathological features of DAP are well known, its genomic characteristics are still evolving, prompting the suggestion that all DAP would benefit from molecular analysis with the purpose of improving tumor recognition, genetic classification, and, ultimately, personalized therapy. Herein, we report a case of DAP with novel genetic alterations (BCOR P1153S, ERG M219I, KDR A750E, POLE S1896P, and RAD21 T461del).PMID:38534951 | PMC:PMC10968787 | DOI:10.3390/curroncol31030118
Source: Current Oncology - Category: Cancer & Oncology Authors: Source Type: research